These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20501573)

  • 1. FDA advisers to assess drug for low sexual desire in women.
    Moynihan R
    BMJ; 2010 May; 340():c2786. PubMed ID: 20501573
    [No Abstract]   [Full Text] [Related]  

  • 2. US drug agency approves drug for low sexual desire in women.
    McCarthy M
    BMJ; 2015 Aug; 351():h4522. PubMed ID: 26292940
    [No Abstract]   [Full Text] [Related]  

  • 3. Flibanserin and its discontents.
    Aftab A; Chen C; McBride J
    Arch Womens Ment Health; 2017 Apr; 20(2):243-247. PubMed ID: 27858170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evening the score on sex drugs: feminist movement or marketing masquerade?
    Moynihan R
    BMJ; 2014 Oct; 349():g6246. PubMed ID: 25354348
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug for low sexual desire carries significant harms, FDA advisers find.
    Moynihan R
    BMJ; 2010 Jul; 341():c3339. PubMed ID: 20610515
    [No Abstract]   [Full Text] [Related]  

  • 6. Flibanserin and Female Sexual Desire.
    Fantasia HC
    Nurs Womens Health; 2016; 20(3):309-14. PubMed ID: 27287358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Margaret McCartney: Flibanserin for low sexual desire is not feminism.
    McCartney M
    BMJ; 2015 Oct; 351():h5650. PubMed ID: 26502743
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of Flibanserin: Science and Advocacy at the FDA.
    Gellad WF; Flynn KE; Alexander GC
    JAMA; 2015 Sep; 314(9):869-70. PubMed ID: 26148201
    [No Abstract]   [Full Text] [Related]  

  • 9. A 'magic bullet' for a lackluster libido? The newly approved Addyi is not yet ready for prime-time women.
    Health After 50 Sci Am Consum Health; 2015 Dec; 27(12):1-2. PubMed ID: 27062743
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: FDA Approves First Treatment for Sexual Desire Disorder.
    Seftel AD
    J Urol; 2016 Apr; 195(4 Pt 1):1073. PubMed ID: 27302804
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA approves female sexual dysfunction drug.
    Mullard A
    Nat Rev Drug Discov; 2015 Oct; 14(10):669. PubMed ID: 26424353
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA Approval of Flibanserin--Treating Hypoactive Sexual Desire Disorder.
    Joffe HV; Chang C; Sewell C; Easley O; Nguyen C; Dunn S; Lehrfeld K; Lee L; Kim MJ; Slagle AF; Beitz J
    N Engl J Med; 2016 Jan; 374(2):101-4. PubMed ID: 26649985
    [No Abstract]   [Full Text] [Related]  

  • 13. Do drugs have a role in turning indifference into passion?
    Hawkes N
    BMJ; 2010 Oct; 341():c5532. PubMed ID: 20923834
    [No Abstract]   [Full Text] [Related]  

  • 14. Consultation corner. The latest on female sexual health.
    DeRogatis LR
    Johns Hopkins Med Lett Health After 50; 2010 Nov; 22(9):6-7. PubMed ID: 21066837
    [No Abstract]   [Full Text] [Related]  

  • 15. Improving prospects for treating hypoactive sexual desire disorder (HSDD): development status of flibanserin.
    Thorp J; Palacios S; Symons J; Simon J; Barbour K
    BJOG; 2014 Oct; 121(11):1328-31. PubMed ID: 24909923
    [No Abstract]   [Full Text] [Related]  

  • 16. The Circle of Female Sexual Desire-Have We Come a Long Way?
    Katz A
    Nurs Womens Health; 2016; 20(3):235-8. PubMed ID: 27287350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flibanserin (Addyi) for Hypoactive Sexual Desire Disorder in Premenopausal Women.
    Holt H; Tingen J
    Am Fam Physician; 2016 May; 93(10):826-8. PubMed ID: 27175717
    [No Abstract]   [Full Text] [Related]  

  • 18. [Flibanserin as pharmacological therapy of inhibited sexual desire in women].
    Eldon AS; Giraldi A
    Ugeskr Laeger; 2017 Feb; 179(7):. PubMed ID: 28397671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoactive sexual desire disorder: inventing a disease to sell low libido.
    Meixel A; Yanchar E; Fugh-Berman A
    J Med Ethics; 2015 Oct; 41(10):859-62. PubMed ID: 26124287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. U.S. Food and Drug Administration Approval of Addyi (Flibanserin) for Treatment of Hypoactive Sexual Desire Disorder.
    Puppo G; Puppo V
    Eur Urol; 2016 Feb; 69(2):379-80. PubMed ID: 26455357
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.